Giles Platford was appointed President of Europe & Canada Business Unit for Takeda in April 2017. He is also a Corporate Officer and has been a member of Takeda’s Executive Team (TET) since 2014, reporting to the company’s President & CEO, Christophe Weber.
A seasoned industry leader with over 15 years of pharmaceutical experience, Mr. Platford was formerly President of Emerging Markets, where he oversaw the launch of Takeda’s innovative pipeline across the region, and led the design and roll-out of Takeda’s global Access to Medicines program.
Previously, Mr. Platford served as Head of the Middle East, Turkey and Africa region, where he strengthened controls and compliance whilst re-engineering the business leading to significant growth. He also held various leadership positions including General Manager Brazil, where he transformed Takeda Brazil into a top 10 pharmaceutical industry player, being externally recognized for the first time as one of the country’s top employers and best companies to work for.
Prior to joining Takeda in 2009, Mr. Platford spent eight years in Asia Pacific, where he assumed a number of roles of increasing responsibility in Business Development, Commercial and General Management.
Since July 2017, Mr. Platford has been representing Takeda as a Board member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
A UK national, Mr. Platford holds a Bachelor of Arts (Honors) degree in Business and Marketing Management from Oxford Brookes University, in the UK.